The Body Keeps Score

Five days. That is the distance between Spencer Strider feeling a "slight pull" in his left oblique during a Minor League start against the Red Sox and the Atlanta Braves placing him on the injured list, three days before they are supposed to open a season that was meant to be about restoration. In the calculus of baseball injuries, five days is both nothing and everything — long enough for an organization to run imaging, consult specialists, and arrive at the careful, calibrated language of managed expectations. Short enough to suggest that what they found was not what they hoped.

Walt Weiss, in his first spring as Braves manager, offered the kind of quote that sounds reassuring only if you don't listen closely: "I think we've gotten out in front of this thing to a degree. So we're hoping it's not going to be a big deal." The operative words — to a degree, hoping, not going to be — belong to a man describing a situation he cannot yet control. And then the quieter admission: "It's hard for him to feel it, but it is there when he throws."

It is there when he throws. Six words that land harder than any MRI report.

This is not Spencer Strider's first oblique strain. It is his second. The first came in September 2022, when Strider was twenty-three years old and already throwing the kind of fastball that made hitters look like they were guessing wrong about physics. He missed roughly two weeks, returned for NLDS Game 3 against the Phillies, and lasted 2.1 innings in a 9-1 loss. The Braves' season ended the next night. What looked at the time like a footnote in a young career now reads differently — as the first entry in a medical history that has become, by volume and variety, the defining text of Strider's professional life.

The full catalogue: UCL tear at Clemson in 2019, Tommy John surgery, the oblique in 2022, then the devastating UCL compromise with a bone fragment in April 2024 that required an internal brace procedure by Dr. Barry Meister. A hamstring injury in 2025. And now this, a second oblique strain in the same region that failed him once before. The body, it turns out, keeps meticulous records.

Strider's 2025 return season told the statistical story with characteristic clarity. Over 23 starts and 125.1 innings — a workload the organization carefully managed — he posted a 4.45 ERA and a 7-14 record. The strikeout rate, which had peaked at a staggering 36.8% during his electric 2023 season, fell to 24.3%. His career numbers remain impressive in aggregate: 455 innings, 626 strikeouts, a K/9 of 12.4, a career ERA of 3.74. But aggregate numbers can be misleading. They smooth out the trajectory, and Strider's trajectory has not been smooth. It has been a series of brilliant ascents interrupted by the mechanical failures of a body asked to do extraordinary things.

He turns twenty-seven in October. By baseball's developmental clock, he should be entering his prime. By his body's clock, he is somewhere else entirely.

On Monday, March 23, Strider was scratched from his scheduled start against the Pirates. The man who replaced him on the mound was Didier Fuentes, who is twenty years old and throws a fastball that touches 99 mph. In 4.2 innings, Fuentes allowed 2 hits, 1 run, walked 1, and struck out 1. It was competent and unremarkable, which is exactly what the Braves needed it to be.

But the symbolism was not lost on anyone paying attention. I wrote about this dynamic in The Fuentes Question — the way the organization has positioned Fuentes as both insurance policy and long-term answer, and the uncomfortable reality that those two roles may be converging faster than anyone planned. Walt Weiss himself drew the comparison to Strider's own electrifying 2022 spring, language that was either genuinely felt or strategically deployed. Probably both.

Fuentes's final spring line was absurd: 13.2 innings pitched, 2 hits, 1 run, 1 walk, 18 strikeouts, a 0.66 ERA, a 0.22 WHIP. These are not real baseball numbers. They are the numbers of a video game played on the easiest difficulty setting. His 2025 MLB debut — 13.85 ERA across 4 starts, 6 home runs in 13 innings — is the necessary corrective, the reminder that spring training numbers and regular-season numbers are different currencies. For Opening Day, he will work out of the bullpen. He is not in the rotation. Not yet. As Dex argued, there is a fine line between developing a prospect and betting a season on one. The Braves, for now, are walking it.

The rotation the Braves imagined in January — Sale, Strider, López, Schwellenbach, Waldrep — no longer exists in any recognizable form. What opens against the Kansas City Royals on Friday at Truist Park will be Sale, López, Grant Holmes, Elder, and someone to be determined, likely Suárez or Pérez. Five arms are on the injured list: Strider with the oblique, Schwellenbach and Waldrep both on the 60-day with elbow procedures, Joey Wentz done for the year with a torn ACL, AJ Smith-Shawver not expected back from Tommy John until 2027.

I called this Five Arms and a Prayer, and three days before the season, the prayer portion of the equation is doing most of the work.

There are reasons for something short of despair. Chris Sale, who starts Opening Day and turns thirty-seven three days later, won the NL Cy Young in 2024 with an 18-3 record and a 2.38 ERA. He remains, by any measure, a legitimate front-of-rotation arm. Grant Holmes allowed zero runs in spring training and posted a 2.73 ERA over 62.2 innings during a strong stretch last season, though his 3.63 FIP suggests some regression is plausible. López is durable and consistent. The bones of a functional rotation exist, if you squint.

But this is a team coming off a 76-86 season, its first losing record since 2017, navigating a managerial transition after Brian Snitker's retirement, absorbing the loss of Ha-Seong Kim to a torn finger tendon until May and Jurickson Profar to a 162-game PED suspension that vaporized $15 million. The margin for error was already thin. Strider's oblique has made it thinner.

Grade 1 oblique strains typically sideline pitchers for approximately a month. The Braves have not publicly specified a grade, which is either because they do not yet know or because they do and prefer not to say. Either interpretation is consistent with the careful, measured tone Weiss has adopted — the tone of a man who understands that the season is one hundred and sixty-two games long, that April baseball is a terrible place to make permanent judgments, and that the best version of Spencer Strider is worth waiting for.

The question is whether the best version of Spencer Strider is still available. Not as a hypothetical, not as a memory of what 36.8% strikeout rates looked like in 2023, but as a physical reality — a twenty-six-year-old arm that can sustain the forces required to miss bats at an elite level over a full season. The oblique is not the UCL. It is not career-threatening in the way that phrase is usually meant. But it is the body's second warning from the same address, and baseball, like the body, has a long memory.

There is a version of this season where Strider returns in late April, finds his fastball command, rebuilds his strikeout rate toward something resembling his former self, and the Braves' depth holds just long enough for the cavalry to arrive. There is also a version where the oblique lingers, where the velocity is there but the conviction is not, where a young man's extraordinary arm continues to betray him in ordinary ways.

The numbers will tell us which version we are living in. They always do. But not yet. Not for a month, at least.